Rank 97 • MedTech & Devices
Tasso
Develops virtual care clinical blood collection devices designed to allow patients to self-sample blood painlessly at home.
Visit website- Signal Score
- 78
- Total raised
- $83M
- Stage
- Series B
- Founded
- 2011
- Headquarters
- Seattle, USA
- Region
- North America
Their signal
Tasso simplifies decentralized clinical trials and remote patient monitoring by eliminating phlebotomy visits, enabling easy, stable blood collection that is shipped directly to clinical labs.
Signal Score 78editorial estimate, see how it is built
Total raised, quality of investors and recency of the last round.
Revenue trajectory, customer count, hiring and market pull.
Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.
Founder track record, clinical depth on the bench and technical leadership.
Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.
Also in MedTech & Devices
Figures are subjective research desk estimates compiled from public sources and refreshed daily, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.